215 related articles for article (PubMed ID: 19124749)
1. Polyanion-induced self-association of complement factor H.
Pangburn MK; Rawal N; Cortes C; Alam MN; Ferreira VP; Atkinson MA
J Immunol; 2009 Jan; 182(2):1061-8. PubMed ID: 19124749
[TBL] [Abstract][Full Text] [Related]
2. Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H.
Meri S; Pangburn MK
Proc Natl Acad Sci U S A; 1990 May; 87(10):3982-6. PubMed ID: 1692629
[TBL] [Abstract][Full Text] [Related]
3. Regulation of alternative pathway complement activation by glycosaminoglycans: specificity of the polyanion binding site on factor H.
Meri S; Pangburn MK
Biochem Biophys Res Commun; 1994 Jan; 198(1):52-9. PubMed ID: 8292049
[TBL] [Abstract][Full Text] [Related]
4. A new map of glycosaminoglycan and C3b binding sites on factor H.
Schmidt CQ; Herbert AP; Kavanagh D; Gandy C; Fenton CJ; Blaum BS; Lyon M; Uhrín D; Barlow PN
J Immunol; 2008 Aug; 181(4):2610-9. PubMed ID: 18684951
[TBL] [Abstract][Full Text] [Related]
5. Complement C3b/C3d and cell surface polyanions are recognized by overlapping binding sites on the most carboxyl-terminal domain of complement factor H.
Hellwage J; Jokiranta TS; Friese MA; Wolk TU; Kampen E; Zipfel PF; Meri S
J Immunol; 2002 Dec; 169(12):6935-44. PubMed ID: 12471127
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Binding Properties of Individual Functional Sites of Human Complement Factor H.
Haque A; Cortes C; Alam MN; Sreedhar M; Ferreira VP; Pangburn MK
Front Immunol; 2020; 11():1728. PubMed ID: 32849614
[TBL] [Abstract][Full Text] [Related]
7. Effects of sulphated polyanions on functions of complement factor H.
Koistinen V
Mol Immunol; 1993 Feb; 30(2):113-8. PubMed ID: 8429830
[TBL] [Abstract][Full Text] [Related]
8. The regulatory SCR-1/5 and cell surface-binding SCR-16/20 fragments of factor H reveal partially folded-back solution structures and different self-associative properties.
Okemefuna AI; Gilbert HE; Griggs KM; Ormsby RJ; Gordon DL; Perkins SJ
J Mol Biol; 2008 Jan; 375(1):80-101. PubMed ID: 18005991
[TBL] [Abstract][Full Text] [Related]
9. Localization of the heparin-binding site on complement factor H.
Pangburn MK; Atkinson MA; Meri S
J Biol Chem; 1991 Sep; 266(25):16847-53. PubMed ID: 1832158
[TBL] [Abstract][Full Text] [Related]
10. Cutting edge: localization of the host recognition functions of complement factor H at the carboxyl-terminal: implications for hemolytic uremic syndrome.
Pangburn MK
J Immunol; 2002 Nov; 169(9):4702-6. PubMed ID: 12391176
[TBL] [Abstract][Full Text] [Related]
11. The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome.
Ferreira VP; Herbert AP; Cortés C; McKee KA; Blaum BS; Esswein ST; Uhrín D; Barlow PN; Pangburn MK; Kavanagh D
J Immunol; 2009 Jun; 182(11):7009-18. PubMed ID: 19454698
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid hormone is a heparin/polyanion binding protein: binding energetics and structure modification.
Kamerzell TJ; Joshi SB; McClean D; Peplinskie L; Toney K; Papac D; Li M; Middaugh CR
Protein Sci; 2007 Jun; 16(6):1193-203. PubMed ID: 17525467
[TBL] [Abstract][Full Text] [Related]
13. Implications of the progressive self-association of wild-type human factor H for complement regulation and disease.
Nan R; Gor J; Perkins SJ
J Mol Biol; 2008 Jan; 375(4):891-900. PubMed ID: 18054958
[TBL] [Abstract][Full Text] [Related]
14. Human factor H-related protein 5 has cofactor activity, inhibits C3 convertase activity, binds heparin and C-reactive protein, and associates with lipoprotein.
McRae JL; Duthy TG; Griggs KM; Ormsby RJ; Cowan PJ; Cromer BA; McKinstry WJ; Parker MW; Murphy BF; Gordon DL
J Immunol; 2005 May; 174(10):6250-6. PubMed ID: 15879123
[TBL] [Abstract][Full Text] [Related]
15. Two distinct conformations of factor H regulate discrete complement-binding functions in the fluid phase and at cell surfaces.
Osborne AJ; Nan R; Miller A; Bhatt JS; Gor J; Perkins SJ
J Biol Chem; 2018 Nov; 293(44):17166-17187. PubMed ID: 30217822
[TBL] [Abstract][Full Text] [Related]
16. Localization of the third heparin-binding site in the human complement regulator factor H1.
Ormsby RJ; Jokiranta TS; Duthy TG; Griggs KM; Sadlon TA; Giannakis E; Gordon DL
Mol Immunol; 2006 Apr; 43(10):1624-32. PubMed ID: 16263173
[TBL] [Abstract][Full Text] [Related]
17. Host recognition and target differentiation by factor H, a regulator of the alternative pathway of complement.
Pangburn MK
Immunopharmacology; 2000 Aug; 49(1-2):149-57. PubMed ID: 10904114
[TBL] [Abstract][Full Text] [Related]
18. Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site.
Jokiranta TS; Cheng ZZ; Seeberger H; Jòzsi M; Heinen S; Noris M; Remuzzi G; Ormsby R; Gordon DL; Meri S; Hellwage J; Zipfel PF
Am J Pathol; 2005 Oct; 167(4):1173-81. PubMed ID: 16192651
[TBL] [Abstract][Full Text] [Related]
19. Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120.
Moulard M; Lortat-Jacob H; Mondor I; Roca G; Wyatt R; Sodroski J; Zhao L; Olson W; Kwong PD; Sattentau QJ
J Virol; 2000 Feb; 74(4):1948-60. PubMed ID: 10644368
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of target recognition in an innate immune system: interactions among factor H, C3b, and target in the alternative pathway of human complement.
Pangburn MK; Pangburn KL; Koistinen V; Meri S; Sharma AK
J Immunol; 2000 May; 164(9):4742-51. PubMed ID: 10779780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
